Molecular recycling within amyloid fibrils

被引:287
作者
Carulla, N
Caddy, GL
Hall, DR
Zurdo, J
Gairí, M
Feliz, M
Giralt, E
Robinson, CV
Dobson, CM
机构
[1] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England
[2] Serv Cient Tecn, Barcelona 08028, Spain
[3] Inst Recerca Biomed Barcelona, Barcelona 08028, Spain
[4] Univ Barcelona, Dept Quim Organ, E-08028 Barcelona, Spain
基金
英国惠康基金;
关键词
D O I
10.1038/nature03986
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Amyloid fibrils are thread-like protein aggregates with a core region formed from repetitive arrays of beta-sheets oriented parallel to the fibril axis(1,2). Such structures were first recognized in clinical disorders(1,3), but more recently have also been linked to a variety of non-pathogenic phenomena ranging from the transfer of genetic information to synaptic changes associated with memory(4-7). The observation that many proteins can convert into similar structures in vitro has suggested that this ability is a generic feature of polypeptide chains(1,8). Here we have probed the nature of the amyloid structure by monitoring hydrogen/deuterium exchange in fibrils formed from an SH3 domain(9-12) using a combination of nuclear magnetic resonance spectroscopy and electrospray ionization mass spectrometry. The results reveal that under the conditions used in this study, exchange is dominated by a mechanism of dissociation and re-association that results in the recycling of molecules within the fibril population. This insight into the dynamic nature of amyloid fibrils, and the ability to determine the parameters that define this behaviour, have important implications for the design of therapeutic strategies directed against amyloid disease.
引用
收藏
页码:554 / 558
页数:5
相关论文
共 30 条
[1]   Direct observation of amyloid fibril growth monitored by thioflavin T fluorescence [J].
Ban, T ;
Hamada, D ;
Hasegawa, K ;
Naiki, H ;
Goto, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (19) :16462-16465
[2]   Role of Escherichia coli curli operons in directing amyloid fiber formation [J].
Chapman, MR ;
Robinson, LS ;
Pinkner, JS ;
Roth, R ;
Heuser, J ;
Hammar, M ;
Normark, S ;
Hultgren, SJ .
SCIENCE, 2002, 295 (5556) :851-855
[3]   Therapeutic approaches to protein-misfolding diseases [J].
Cohen, FE ;
Kelly, JW .
NATURE, 2003, 426 (6968) :905-909
[4]   Protein aggregation and amyloid fibril formation by an SH3 domain probed by limited proteolysis [J].
de Laureto, PP ;
Taddei, N ;
Frare, E ;
Capanni, C ;
Costantini, S ;
Zurdo, J ;
Chiti, F ;
Dobson, CM ;
Fontana, A .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 334 (01) :129-141
[5]   In the footsteps of alchemists [J].
Dobson, CM .
SCIENCE, 2004, 304 (5675) :1259-+
[6]   Protein folding and misfolding [J].
Dobson, CM .
NATURE, 2003, 426 (6968) :884-890
[7]   Hydrogen exchange [J].
Englander, SW ;
Krishna, MMG .
NATURE STRUCTURAL BIOLOGY, 2001, 8 (09) :741-742
[8]   Watching amyloid fibrils grow by time-lapse atomic force microscopy [J].
Goldsbury, C ;
Kistler, J ;
Aebi, U ;
Arvinte, T ;
Cooper, GJS .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 285 (01) :33-39
[9]   Silent prions lying in wait: A two-hit model of prion/amyloid formation and infection [J].
Hall, D ;
Edskes, H .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 336 (03) :775-786
[10]   Engineering amyloidogenicity towards the development of nanofibrillar materials [J].
Hamada, D ;
Yanagihara, I ;
Tsumoto, K .
TRENDS IN BIOTECHNOLOGY, 2004, 22 (02) :93-97